Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a clinical-stage biopharmaceutical company developing a novel therapeutic that targets soluble amyloid beta oligomers (AβOs) for the treatment of Alzheimer ...

Liverpool have been all over the place this season, and very few of the new signings have been able to live up to their price tags. It's imperative that we see the team recover from their slump.Arne ...